Tarek Haykal, Smit Deliwala, Thomas L. Ortel
Abstract
Open-access reader
To the Editor,Warfarin is a well-known vitamin K antagonist (VKA) established for decades for a variety of clinical indications, including venous thromboembolism (VTE), prevention of cardioembolic ...
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
To the Editor,Warfarin is a well-known vitamin K antagonist (VKA) established for decades for a variety of clinical indications, including venous thromboembolism (VTE), prevention of cardioembolic ...
Key concepts: Vitamin K antagonist, Warfarin, Venous thromboembolism, Medicine, Vitamin k, Intensive care medicine, Vitamin K epoxide reductase, Internal medicine